Fat emulsions are high-value pharmaceutical products formulated as oil-in-water (O/W) dispersions. Clinically, they supply energy and essential fatty acids for the human body, sustain cellular structural integrity and modulate immune functions. Characterised by fine, uniformly distributed particle sizes, superior physical stability and inherent targeting properties, fat emulsions have become a pivotal research direction to enhance therapeutic efficacy of formulated drugs. Driven by advances in the pharmaceutical industry, clinical and industrial applications of fat emulsions have expanded substantially in recent years. Drawing on extensive engineering expertise in formulation system design for complex pharmaceutical dispersions, Sino Bioengineering delivers turnkey technical solutions for full-scale fat emulsion manufacturing projects worldwide.
1. Turnkey Fat Emulsion Formulation Engineering Solution from Sino Bioengineering with Mixing Precision up to 0.1%
Commercially available fat emulsions fall into two primary categories: injectable formulations and oral preparations, while injectable variants are further split into nutritional fat emulsions and drug-loaded carrier emulsions. Distinct from conventional parenteral injections, injectable fat emulsions are typically composed of liquid oily substrates, phospholipid emulsifiers, isotonic agents and Water for Injection (WFI) to form stable O/W globule dispersions. Per the requirements specified in Chinese Pharmacopoeia 2020 Edition, for intravenous emulsion injections, no less than 90% of globules shall have a particle size below 1 μm, and globules exceeding 5 μm shall be absent unless otherwise specified in monographs. As a sophisticated complex formulation, critical quality attributes including globule particle size and its distribution profile as well as encapsulation efficiency directly govern in-vivo drug release behaviour and clinical performance. The formulation stage constitutes the core manufacturing procedure dictating these key quality parameters, with emulsification, homogenisation, microbial control and cleaning protocols all exerting decisive impacts on final drug quality.
Customised full-process engineering design is available at Sino Bioengineering in line with clients’ predefined formulation ratios, covering proportional ingredient batching design, emulsification process engineering and homogeniser model selection. Our technical team resolves prevalent industrial challenges such as residual oxygen containment during compounding and leftover bulk liquor management upon completion of homogenisation inside process vessels.
2. Multi-stage Homogenisation Enabled Formulation System for Controlled Particle Size and ≥98% Process Yield
Homogenisation is the core unit operation determining finished emulsion quality and generating finely dispersed, narrowly distributed globules. According to specifications outlined in the United States Pharmacopeia (USP), the fraction of globules larger than 5 μm must not surpass 0.05%, whereas Sino Bioengineering’s tailored formulation system is engineered to cap this oversized particle ratio at ≤0.02%. To mitigate oversized globule and free oil droplet formation throughout compounding, our seasoned engineering specialists rationalise homogenisation recirculation workflows and conduct scientific model selection for homogenisers and inline filters. Block valve configuration and optimised pipeline routing minimise dead-leg volumes and residual hold-up, ensuring complete bulk liquor passes through repeated homogenisation cycles to curb coarse droplet generation; downstream inline filtration further eliminates oversized globules prior to finished product tank transfer, with an additional polishing filtration step installed between finished product holding tank and filling station for secondary particle control.
Maximising manufacturing yield remains a persistent focal point for fat emulsion process optimisation. Sino Bioengineering improves cost-effectiveness for manufacturers via continuous process refinement: besides preventing premature primary emulsion breakdown, full recovery of residual vessel liquor represents another core yield-improving measure. Our proprietary formulation system fully collects residual bulk solution retained in homogenisation vessels post-batch processing, securing a final process yield of no less than 98%.
Upon project handover, Sino Bioengineering’s technical engineers provide full on-site technical supervision for the first production batch, delivering rapid troubleshooting and tailored remedies against unforeseen process abnormalities to guarantee regulatory-compliant finished products and realise full-cycle after-sales service closure.
3. Automated Formulation with Segregated CIP Design: Physical Isolation Prevents Cross-contamination and Reduces Cleaning Cycle Duration
Sino Bioengineering’s fat emulsion formulation system supports fully automated batching and material transfer, equipped with automated Clean-in-Place (CIP) and Sterilise-in-Place (SIP) modules. The CIP system autonomously judges cleaning endpoint by online conductivity monitoring, while the SIP module verifies sterilisation efficacy via continuous temperature tracking at vessel low-points. Strict upstream bioburden control is embedded into system design: raw oil feeds into oil-phase preparation tanks via sterile depth filtration, and pre-formulated aqueous phase undergoes sterile filtration prior to being transferred into dedicated aqueous-phase tanks, effectively restricting microbial load and extraneous particulate contamination originating from raw materials, excipients and WFI during feeding operations.
Prior to physical fabrication, three-dimensional modelling is deployed for full layout design of the formulation system. Pipeline routing strictly adheres to 3D dead-leg design specifications stipulated in pharmaceutical engineering guidelines; detailed 3D drafting visualises every single unit component, facilitating client layout revision and serving as precise construction guidance.
Modular segregated CIP architecture is adopted in our system, enabling independent cleaning circuits for: (1) oil-phase tanks plus associated pipelines; (2) aqueous-phase tanks plus associated pipelines; (3) primary emulsion preparation tanks, homogenisation tanks and connected process piping; (4) finished product tanks and filling feed pipelines. Complete physical isolation between discrete CIP loops eliminates cross-contamination risks during sanitation and shortens overall cleaning runtime through split sequential cleaning cycles.
Committed to supplying optimised fat emulsion formulation turnkey solutions, Sino Bioengineering helps pharmaceutical manufacturers tackle core challenges covering automated compounding deployment and cleaning validation execution. Automated formulation configurations cut human-induced operational errors, narrow batch-to-batch quality variability, slash labour expenditure and deliver superior inter-batch product consistency.
As a leading process-oriented engineering company, Sino Bioengineering delivers professional bioengineering solutions and comprehensive technical services to clients worldwide.
For more products and solutions: https://sinobioengg.com/category/solution/
For more service: https://sinobioengg.com/category/service/
